|
WO2021030240A1
|
|
Treatment of cancers with antibody drug conjugates (adc) that bind to 191p4d12 proteins
|
|
WO2020117373A1
|
|
Pharmaceutical compositions comprising anti-191p4d12 antibody drug conjugates and methods of use thereof
|
|
CN111051345A
|
|
Nectin-4 binding proteins and methods of use thereof
|
|
EP3297662A1
|
|
Antibodies that bind to axl proteins
|
|
US2018134793A1
|
|
Antibodies that bind to AXL proteins
|
|
AR103896A1
|
|
ANTI-PROTEIN FLT3 ANTI-PROTEIN DRUGS (ADC)
|
|
AU2015234335A1
|
|
Antibody drug conjugates (ADC) that bind to 191P4D12 proteins
|
|
US2017190735A1
|
|
Derivatives of dolaproine-dolaisoleuine peptides
|
|
SG11201600587VA
|
|
Antibody drug conjugates (adc) that bind to cd37 proteins
|
|
WO2014043403A1
|
|
Amatoxin derivatives and cell-permeable conjugates thereof as inhibitors of rna polymerase
|
|
CN105073132A
|
|
Antibody drug conjugates (ADC) that bind to 158P1D7 proteins
|
|
AU2012202262A1
|
|
Nucleic acids and corresponding proteins entitled 282P1G3 useful in treatment and detection of cancer
|
|
TW201216987A
|
|
Antibody drug conjugates (adc) that bind to 191p4d12 proteins
|
|
TW201138818A
|
|
Antibody drug conjugates (adc) that bind to 161p2f10b proteins
|
|
JP2010220621A
|
|
Nucleic acid entitled as 98p4b6 and corresponding protein useful in treatment and detection of cancer
|
|
US2010260756A1
|
|
Antibodies and related molecules that bind to 161P2F10B proteins
|
|
EP2403524A1
|
|
Antibody drug conjugates (adc) that bind to 24p4c12 proteins
|
|
JP2010151822A
|
|
Nucleic acid and correspondence protein called 24p4c12 useful in treating and detecting cancer
|
|
WO2010022279A1
|
|
Antibodies and related molecules that bind to 58p1d12 proteins
|
|
TW201021828A
|
|
Antibodies and related molecules that bind to 58P1D12 proteins
|
